OAM
IDYA icon

Oppenheimer Asset Management’s IDEAYA Biosciences IDYA Stock Holding History

Oppenheimer Asset Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$553K Sell
14,847
-597
-4% -$18.3K 0.01% 874
2026
Q1 		$515K Sell
15,444
-285
-2% -$9.56K 0.01% 863
2025
Q4 		$544K Sell
15,729
-577
-4% -$18.4K 0.01% 807
2025
Q3 		$444K Buy
16,306
+2,519
+18% +$60.9K ﹤0.01% 922
2025
Q2 		$290K Buy
13,787
+2,227
+19% +$42.7K ﹤0.01% 1001
2025
Q1 		$189K Buy
11,560
+2,884
+33% +$61.4K ﹤0.01% 1059
2024
Q4 		$223K Sell
8,676
-3,382
-28% -$95.7K ﹤0.01% 1055
2024
Q3 		$382K Sell
12,058
-155
-1% -$5.88K ﹤0.01% 937
2024
Q2 		$429K Buy
12,213
+1,747
+17% +$69.2K 0.01% 891
2024
Q1 		$459K Buy
+10,466
New +$450K 0.01% 855

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Oppenheimer Asset Management's IDYA Position: Q2 2026 in Review

Oppenheimer Asset Management reduced its IDEAYA Biosciences (IDYA) stake by 3.9% in Q2 2026, selling an estimated $18.3K and leaving 14,847 shares worth $553K. The position accounts for 0.01% of the portfolio, ranked #874.

Oppenheimer Asset Management first reported a position in IDYA in Q1 2024 and has held it in 10 quarters since. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Oppenheimer Asset Management held 14,847 shares of IDEAYA Biosciences worth $553K as of Q2 2026.
  • Oppenheimer Asset Management sold 597 IDEAYA Biosciences shares in Q2 2026, an estimated $18.3K.
  • IDEAYA Biosciences made up 0.01% of Oppenheimer Asset Management's portfolio in Q2 2026, its #874 holding.
  • Oppenheimer Asset Management first reported a position in IDEAYA Biosciences in Q1 2024 and has held it in 10 quarters since.
  • 284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Oppenheimer Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.